This paper is only available as a PDF. To read, Please Download here.
Abstract
A vaccine was developed against bovine mastitis based on inactivated, highly encapsulated Staphylococcus aureus cells; a crude extract of Staph. aureus exopolysaccharides; and inactivated, unencapsulated Staph. aureus and Streptococcus spp. cells. This vaccine was tested on 30 heifers during a 7-mo period. The 30 heifers were randomly assigned to three groups of 10 heifers each. The prepartum group received two injections of the vaccine at 8 and 4 wk before calving, and the postpartum group received two injections at 1 and 5 wk after calving. The control group received two injections of a placebo at 8 and 4 wk before calving. The vaccine or the placebo was administered subcutaneously in the brachiocephalicus muscle of the neck. The frequencies of intramammary infections caused by Staph. aureus were reduced from 18.8% for heifers in the control group to 6.7 and 6.0% for heifers in the prepartum and post-partum groups, respectively. This protective effect was maintained for at least 6 mo. The relative risk of mastitis caused by Staph. aureus was 0.31 and 0.28 for heifers in the prepartum and postpartum groups, respectively, compared with that for heifers in the control group. The results of the trial indicated the effectiveness of the vaccine in decreasing the incidence of intramammary infections caused by Staph. aureus. A slight but nonsignificant increase occurred in fat production in the milk of vaccinated cows. The vaccine had no observable effect on somatic cell count or streptococcal infections.
Key words
Abbreviation Key:
CNS (coagulase-negative staphylococci)References
- Predominance of two newly described capsular polysaccharide types among clinical isolates of S. aureus.Diagn. Microbiol. Infect. Dis. 1984; 2: 85
- Estimación de las pérdidas en volumen de producción de leche provocadas por la mastitis bovina en la República Argentina.Comm. Fed. Lechería Arch. Lechería. 1983; 6: 73
- Field trials of a vaccine against bovine mastitis. 2. Evaluation in two commercial dairy herds.J. Dairy Sci. 1997; 80: 854
- Epi Info®, Version 6.Ctr. Dis. Control Prev., Atlanta, GA1994
- Local vaccination with killed Streptococcus uberis protects the bovine mammary gland against experimental intramammary challenge with the homologous strain.Infect. Immun. 1994; 62: 3599
- Characteristics of coagulase-positive and coagulase-negative staphylococci in serum-soft agar.J. Bacteriol. 1958; 75: 339
- Potential for vaccination against infections caused by Staphylococcus aureus.Vaccine. 1991; 9: 221
- Effects of segregation on prevention of intramammary infections by Staphylococcus aureus.J. Dairy Sci. 1989; 72: 540
- Manual de Aná lisis Químicos y Clínicos.3rd ed. Editorial Médica Panamericana, Buenos Aires, Argentina1975
- Etiología de la mastitis bovina.Rev. Med. Vet. (B. Aires). 1980; 61: 43
- Recuento de células somáticas en leche bovina de cuartos mamarios con aislamiento negativo e infectados.Rev. Med. Vet. (B. Aires). 1995; 76: 6
- Evaluación de técnicas y procedimientos utilizados en el diagnóstico, prevención y control de la mastitis bovina.in: Kitroser J. II Congr. Nacional de Lechería, Venado Tuerto, Santa Fe, Argentina. Inst. Ganadero, Pergamino, Argentina1993: 66
- Investigación en mastitis subclínica. II. Agentes etiológicos bacterianos.Rev. Med. Vet. (B. Aires). 1980; 61: 225
- Effect of anticapsular antibodies on neutrophil phagocytosis of Staphylococcus aureus.J. Dairy Sci. 1991; 74: 3360
- Protective effect of previous intramammary infection with S. uberis against subsequent clinical mastitis in the cow.Res. Vet. Sci. 1988; 44: 366
- A monograph on bovine mastitis.Int. Dairy Fed., Brussels, Belgium1971 (IDF Bull. No. 60)
- Somatic cells in milk.Their significance and recommended method for counting. Int. Dairy Fed., Brussels, Belgium1979 (IDF Bull. No. 114)
- Staphylococcus aureus exopolysaccharide in vivo demonstrated by immunomagnetic separation and electron microscopy.J. Clin. Microbiol. 1989; 27: 1631
- The toxic shock syndrome exotoxin structural gene is not detectably transmitted by a prophage.Nature (Lond.). 1983; 305: 709
- Clinical features of consecutive intramammary infection with Streptococcus agalactiae in vaccinated and nonvaccinated heifers.Vet. Rec. 1983; 14: 472
- Incidence of udder infections arising at various stages of lactation of cows.Aust. Vet. J. 1968; 44: 543
- Vaccination programs for preventing and controlling mastitis.in: Proc. Natl. Mastitis Counc. Reg. Mtg., Syracuse, NY. Natl. Mastitis Counc., Inc., Arlington, VA1993: 64
- Effect of a Staphylococcus aureus bacterin on serum antibody, new infection, and mammary histology in nonlactating dairy cows.J. Dairy Sci. 1993; 76: 1290
- Encapsulation of Staphylococcus aureus isolated from bovine milk.Vet. Microbiol. 1983; 8: 397
- A field trial with an experimental vaccine against Staphylococcus aureus mastitis in cattle. 1. Clinical parameters.J. Dairy Sci. 1994; 77: 1267
- A field trial with an experimental vaccine against Staphylococcus aureus mastitis in cattle. 2. Antibody response.J. Dairy Sci. 1994; 77: 1276
Odierno, L. 1994. Estudios genéticos, fisiológicos e inmunológicos de la cápsula de Staphylococcus aureus. Ph.D. Diss., Univ. Nacional Río Cuarto, Argentina.
- Elevada frecuencia de Staphylococcus aureus capsulados en leche bovina en Argentina.Rev. Med. Vet. (B. Aires). 1992; 47: 51
- Comparación de métodos de detección de cápsula en Staphylococcus aureus.Rev. Latinoam. Microbiol. 1995; 37: 245
- Variation in the incidence of udder infection and mastitis with stage in lactation age and season of the year.J. Dairy Res. 1956; 23: 181
- Frequency and immunologic cross-reactivity of encapsulated Staphylococcus aureus in bovine milk in New York.Am. J. Vet. Res. 1983; 44: 986
- Antibodies in bovine serum and lacteal secretions to capsular antigens of S. aureus.Am. J. Vet. Res. 1985; 46: 1561
- Influence of encapsulation on staphylococcal opsonization and phagocytosis by human polymorphonuclear leukocytes.J. Immunol. 1978; 19: 943
- Prevalence of capsular polysaccharide types 5 and 8 among Staphylococcus aureus isolates from cow, goat, and ewe milk.J. Clin. Microbiol. 1988; 26: 8
Quattro Pro® Version 5 User's Guide. 1989. Borland Int. Inc., Scotts Valley, CA.
- Immunization against mastitis: a practical goal?.Flemish Vet. J. 1991; 62: 141
- Identification of staphylococci from bovine milk in Argentina.Zentralbl. Bakteriol. 1993; 214: 135
- Worldwide opportunities in genetically engineered vaccines.Bio/Technology (New York). 1987; 5: 1154
- Resistance to Staphylococcus aureus infections in staphylococcal vaccinated heifers.in: Proc. Int. Symp. Bovine Mastitis. Natl. Mastitis Counc. and Am. Assoc., Bovine Pract., Indianapolis, IN1990: 69
- Epidemiology of mastitis.in: Saran A. Soback S. 3rd Int. Mastitis Sem., Tel-Aviv, Israel. M. Lachmann Printers Ltd., Haifa, Israel1995: 3
- Virulence factors involved in the pathogenesis of bovine intramammary infections due to Staphylococcus aureus.J. Med. Microbiol. 1994; 40: 79
- Application of event time analysis to replacement, health and reproduction data in dairy cattle research.Prev. Vet. Med. 1988; 5: 239
- A field trial to test the efficacy of a staphylococcal mastitis vaccine in commercial dairies in Australia.in: Proc. Int. Symp. Bovine Mastitis. Natl. Mastitis Counc. and Am. Assoc, Bovine Pract., Indianapolis, IN1990: 73
- Etiological agents of bovine mastitis.Vet. Microbiol. 1988; 16: 41
- Methods in Immunology and Immunochemistry. Vol. III. Academic Press, New York, NY1970
- Demonstration of serologically different capsular types among strains of Staphylococcus aureus by serumsoft agar technique.Infect. Immun. 1971; 3: 535
- Relation of mucoid growth of Staphylococcus aureus to clumping factor reaction, morphology in serum-soft agar, and virulence.J. Bacteriol. 1968; 96: 902
- Staphylococcal capsular vaccine for preventing mastitis in two herds in Georgia.J. Dairy Sci. 1984; 67: 620
Article info
Publication history
Accepted:
August 23,
1996
Received:
December 27,
1995
Identification
Copyright
© 1997 American Dairy Science Association. Published by Elsevier Inc.
User license
Elsevier user license | How you can reuse
Elsevier's open access license policy

Elsevier user license
Permitted
For non-commercial purposes:
- Read, print & download
- Text & data mine
- Translate the article
Not Permitted
- Reuse portions or extracts from the article in other works
- Redistribute or republish the final article
- Sell or re-use for commercial purposes
Elsevier's open access license policy